Pain medicine

Minimal important difference in postoperative morphine consumption after hip and knee arthroplasty using nausea, vomiting, sedation and dizziness as anchors

Acta Anaesthesiol ScandPublished Post hoc analysis of three randomised trials and cohort studies

Primary result · Difference in iv morphine consumption, no vs only mild eventsResult — go to the resultHodges-Lehmann median difference 6 mg 95% CI 4–8

Authors' conclusion

In populations comparable to this post-hoc analysis (orthopaedic surgery, median age 70 and ASA 2), we suggest a minimally important difference of 5 mg for 0-24 h postoperative iv morphine consumption.

Study context

Population
Patients after hip or knee arthroplasty (PANSAID, DEX-2-TKA and Pain Map studies); median age 70, median ASA 2, 54% female3 studies
Comparison
0–24 h postoperative iv morphine equivalent consumption by severity of opioid-related adverse events (nausea, vomiting, sedation, dizziness)
Primary endpoint
Difference in morphine consumption between patients with no vs only mild events
Follow-up
0–24 h postoperative
Methodological detailsanchor-based methods
  • Anchor-based methods

Primary result

As reported in the abstract

Difference in iv morphine consumption, no vs only mild events · 0–24 h

Hodges-Lehmann median difference

6 mg

95% CI 4–8

Mild vs No events
Hodges-Lehmann median difference 6 mg (95% CI 4–8)

Secondary outcomes

OutcomeHodges-Lehmann median difference (mg) (CI)
Difference in iv morphine consumption, mild vs moderate events · 0–24 h5 (2–8)
Difference in iv morphine consumption, moderate vs severe events · 0–24 h0 (−4 to 4)

Original publication

Minimal important difference in postoperative morphine consumption after hip and knee arthroplasty using nausea, vomiting, sedation and dizziness as anchors. Acta Anaesthesiol Scand. Published 21 February 2024. doi:10.1111/aas.14388

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.